Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE LIVE 15:54 | 25 Sep | 576.90 |
-6.90 (-1.18%) |
OPEN
590.00 |
HIGH
594.40 |
LOW
566.15 |
| NSE 15:56 | 25 Sep | 577.20 |
-8.15 (-1.39%) |
OPEN
581.90 |
HIGH
594.40 |
LOW
564.35 |
| OPEN | 590.00 |
| PREVIOUS CLOSE | 583.80 |
| VOLUME | 126721 |
| 52-Week high | 621.90 |
| 52-Week low | 479.00 |
| P/E | 48.60 |
| Mkt Cap.(Rs cr) | 46,423 |
| Buy Price | 577.95 |
| Buy Qty | 5.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Sun Pharma.Inds. | 505.90 | -1.44 | 121380.58 | 6208.79 | -320.70 | 0.00 | - |
| Cadila Health. | 481.55 | -1.55 | 49296.27 | 2197.30 | 125.10 | 6.78 | 71.03 |
| Piramal Enterp. | 2704.85 | -1.51 | 46672.18 | 2245.75 | 247.46 | 32.49 | 83.25 |
| Cipla | 576.90 | -1.18 | 46423.14 | 3525.05 | 425.78 | 11.87 | 48.60 |
| Lupin | 991.30 | -2.20 | 44786.93 | 3869.58 | 359.12 | 53.47 | 18.54 |
| Aurobindo Pharma | 702.55 | -2.97 | 41162.40 | 3678.75 | 518.33 | 27.70 | 25.36 |
| Dr Reddy's Labs | 2417.50 | -1.59 | 40101.49 | 3333.20 | 56.80 | 58.34 | 41.44 |
| Divi's Lab. | 952.10 | -1.74 | 25273.49 | 820.70 | 231.47 | 34.96 | 27.23 |
| Alkem Lab | 1831.95 | 1.78 | 21900.96 | 1295.24 | 63.78 | 62.21 | 29.45 |
| Torrent Pharma. | 1232.55 | -2.39 | 20857.21 | 1374.00 | 188.00 | 35.52 | 34.70 |
| Biocon | 342.65 | -3.45 | 20559.00 | 927.40 | 97.70 | 7.21 | 47.52 |
| Glaxosmi. Pharma | 2426.50 | -0.06 | 20552.45 | 607.09 | 26.42 | 29.85 | 81.29 |
| Glenmark Pharma. | 613.30 | -2.32 | 17307.33 | 2363.00 | 333.38 | 71.56 | 8.57 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
